SEC Form 4 · accession 0001209191-18-054823
AMICUS THERAPEUTICS, INC. · FOLD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David Michael Clark
Officer — Chief People Officer
Period of report
Oct 9, 2018
Accepted (ET)
Oct 11, 2018 · 6:31 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001178879
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Oct 9, 2018 | A | 56,012 | $0.00 | A | 57,770 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (right to buy)F3 | $12.84 | Oct 9, 2018 | A | 84,842 | A | — | Oct 9, 2028 | Common Stock | 84,842 | 84,842 | D |
Explanation of responses
- F1Granted in the form of restricted stock units which, upon vesting, are settled in exchange for shares of the Company's common stock. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock.
- F2The restricted stock units vest over a four year period with 25% of the total number of shares vesting on the first anniversary of the grant, followed by 25% on each successive grant date anniversary.
- F3These stock options vest and become exercisable in a series of installments. The first installment, which consists of 25% of the total aggregate number of stock options granted, vest and become exercisable on October 9, 2019. The remaining options vest and become exercisable in a series of thirty-five successive monthly installments beginning on November 1, 2019.